LBO — ASPIRUS MERRILL HOSPITAL
IRR: 16.1% | MOIC: 2.11x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.1%
IRR
2.11x
MOIC
$36.0M
Entry EV
$53.1M
Exit EV
$18.5M
Equity Invested
Sources & Uses
S&UTotal · $36.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $14.0M | 38.8% | |
| Sub Debt | $3.5M | 9.7% | |
| Equity | $18.5M | 51.5% | |
| Enterprise Value | $34.9M | 97.1% | |
| Transaction Fees | $1.0M | 2.9% | |
| Total Uses | $36.0M | 100.0% |
Interpretation
INTAt 2.11x MOIC and 16.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $5.1M |
| Exit Ev | $53.1M |
| Net Debt At Exit | $14.1M |
| Equity At Exit | $39.1M |
| Equity Invested | $18.5M |
| Total Value Created | $20.5M |
| Value From Growth | $16.5M |
| Value From Multiple | $1.7M |
| Value From Deleveraging | $3.4M |